Home > Products > CD3 & SCLC1 > Recombinant Anti-CD3 x Anti-SCLC1 Bispecific Antibody (scIgG)

Recombinant Anti-CD3 x Anti-SCLC1 Bispecific Antibody (scIgG)  (SCIGG-103)

Recombinant Anti-CD3 x Anti-SCLC1 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD3 and anti-SCLC1 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Small cell lung cancer therapy.

Specifications

Targets
CD3 & SCLC1
Type
Single chain IgGs
Species Reactivity
Human
Target 1
CD3
Host Animal 1
Mouse
Target 2
SCLC1
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Small cell lung cancer

Targets

Target 1
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Target 2
SCLC1
Gene ID
Alternative Names
SCCL; SCLC; SCLC1; small cell cancer of the lung

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-SCLC1 Bispecific Antibody (scIgG) (SCIGG-103). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD3 & SCLC1"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: